Education
About Us
Working with TipRanks
Follow Us
Taiko Pharmaceutical Co., Ltd. (JP:4574)
:4574
4574 Stock Chart & Stats
¥297.00
-¥2.00(-0.62%)
At close: 4:00 PM EST
¥297.00
-¥2.00(-0.62%)
Day’s Range― - ―
52-Week Range¥228.00 - ¥444.00
Previous CloseN/A
Volume146.60K
Average Volume (3M)93.84K
Market Cap
¥14.87B
Enterprise Value¥12.21B
Total Cash (Recent Filing)¥4.53B
Total Debt (Recent Filing)¥2.03B
Price to Earnings (P/E)17.5
Beta0.87
Next Earnings
Feb 13, 2026EPS EstimateN/A
Last Dividend Ex-Date
Dec 29, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)7.76
Shares Outstanding50,636,900
10 Day Avg. Volume93,940
30 Day Avg. Volume93,840
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)2.09
Price to Sales (P/S)2.64
P/FCF Ratio81.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)935.75
Revenue Forecast (FY)¥982.53B
Taiko Pharmaceutical Co., Ltd. News
4574 FAQ
What was Taiko Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Taiko Pharmaceutical Co., Ltd. lowest stock price was ¥228.00 and its highest was ¥444.00 in the past 12 months.
What is Taiko Pharmaceutical Co., Ltd.’s market cap?
Taiko Pharmaceutical Co., Ltd.’s market cap is ¥14.87B.
When is Taiko Pharmaceutical Co., Ltd.’s upcoming earnings report date?
Taiko Pharmaceutical Co., Ltd.’s upcoming earnings report date is Feb 13, 2026 which is in 71 days.
How were Taiko Pharmaceutical Co., Ltd.’s earnings last quarter?
Taiko Pharmaceutical Co., Ltd. released its earnings results on Nov 11, 2025. The company reported ¥7.76 earnings per share for the quarter, beating the consensus estimate of N/A by ¥7.76.
Is Taiko Pharmaceutical Co., Ltd. overvalued?
According to Wall Street analysts Taiko Pharmaceutical Co., Ltd.’s price is currently Overvalued.
Does Taiko Pharmaceutical Co., Ltd. pay dividends?
Taiko Pharmaceutical Co., Ltd. pays a Semiannually dividend of ¥13 which represents an annual dividend yield of N/A. See more information on Taiko Pharmaceutical Co., Ltd. dividends here
What is Taiko Pharmaceutical Co., Ltd.’s EPS estimate?
Taiko Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Taiko Pharmaceutical Co., Ltd. have?
Taiko Pharmaceutical Co., Ltd. has 50,636,900 shares outstanding.
What happened to Taiko Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Taiko Pharmaceutical Co., Ltd. reported an EPS of ¥7.76 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.709%.
Which hedge fund is a major shareholder of Taiko Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4574
Company Description
Taiko Pharmaceutical Co., Ltd.
Taiko Pharmaceutical Co., Ltd. (4574) is a Japanese pharmaceutical company focused on the development, manufacturing, and sale of prescription drugs. The company operates primarily in the therapeutic areas of infectious diseases, oncology, and central nervous system disorders. Taiko Pharmaceutical is known for its innovative drug formulations and commitment to research and development, enabling it to provide effective treatments to improve patient outcomes.
Technical Analysis
Wakamoto Pharmaceutical Co., Ltd.
―
Morishita Jintan Co., Ltd.
―
Fuso Pharmaceutical Industries,Ltd.
―
Nippon Chemiphar Co., Ltd.
―
Symbio Pharmaceuticals Limited
―